If Rejuran Healer introduced the world to PDRN (polydeoxyribonucleotide) therapy, exosomes are the next chapter. Both treatments work on the principle of biological regeneration — using your body's own repair mechanisms rather than adding foreign substances — but they approach it from different angles.
Korea is at the global forefront of both technologies. The treatments are widely available in Seoul at prices a fraction of what they cost (or will cost) in Western markets. Here's what you need to know.
PDRN: The Proven Foundation
PDRN (polydeoxyribonucleotide) is a biological polymer derived from salmon DNA. When injected into the skin, it binds to adenosine A2A receptors and triggers a cascade of regenerative responses: increased fibroblast activity, enhanced collagen synthesis, improved blood flow, and reduced inflammation.
PDRN has extensive clinical evidence behind it — originally developed for wound healing, it's been adapted for aesthetic dermatology with strong results in improving skin texture, elasticity, and overall quality. In Korea, PDRN is the active ingredient in Rejuran Healer and has been used in millions of treatments since its introduction.
Exosomes: The New Frontier
Exosomes are extracellular vesicles — tiny packets released by cells that carry growth factors, RNA, and signaling proteins. When applied to or injected into skin, exosomes communicate with target cells to promote regeneration, reduce inflammation, and accelerate healing.
The key advantage of exosomes over PDRN: they deliver a broader range of biological signals. While PDRN works primarily through a single receptor pathway, exosomes can influence multiple cellular processes simultaneously — making them potentially more versatile for complex skin concerns.
Korean clinics are pioneering clinical exosome applications. Several Korean biotech companies (EXOCOBIO, Cellbiotech) produce medical-grade exosome products that are KFDA-approved for aesthetic use.
PDRN vs. Exosomes: Which Should You Choose?
| Factor | PDRN (Rejuran) | Exosomes |
|---|---|---|
| Clinical evidence | Extensive (10+ years) | Growing (newer) |
| Mechanism | Single pathway (A2A receptor) | Multi-pathway signaling |
| Best for | Texture, pores, fine lines | Anti-aging, healing, sensitive skin |
| Results onset | 4–8 weeks | 2–4 weeks |
| Duration | 6–12 months | 6+ months |
| Seoul price | ₩200K–400K | ₩300K–700K |
Many Korean dermatologists now combine both — using PDRN as a foundation for skin quality and exosomes as an accelerator for regeneration. This combination approach is something you'll find in Seoul that's essentially unavailable elsewhere.
Both treatments are unavailable or extremely expensive outside of Asia. Getting them in Seoul means access to practitioners with years of experience at a fraction of the global price. For a comparison of all available skin boosters, see our skin booster comparison guide.
Want to try clinical Korean skincare? We're bringing Seoul's clinical-grade PDRN serums, peptide treatments, and derma creams to the US. Get notified when we launch →